|
| Press Releases |
|
 |
|
| Wednesday, July 16, 2025 |
|
|
AATec Medical 與 Northway Biotech 宣布合作開發用於治療肺部疾病的 ATL-105 工業化生產工藝 |
| AATec Medical GmbH（以下簡稱「AATec」）是一家致力於開發用於治療呼吸系統疾病多產品平台的生物技術公司。Northway Biotech（以下簡稱「Northway Biotech」或「NBT」）是一家全球合同開發與製造組織（CDMO）。兩家公司今日宣布建立合作關係，聯合開展 AATec 旗下主要候選產品 ATL-105 的生產製程開發與分析方法開發。ATL-105 是一種專有的重組 α1-抗胰蛋白酶（AAT）吸入式療法，適用於治療非囊性纖維化支氣管擴張症（NCFB）。 more info >> |
|
|
AATec Medical 与 Northway Biotech 宣布合作开发用于治疗肺部疾病的 ATL-105 工业化生产工艺 |
| AATec Medical GmbH（简称“AATec”）是一家致力于开发用于治疗呼吸系统疾病的多产品平台的生物技术公司。 Northway Biotech（简称“Northway Biotech”或“NBT”）是一家全球合同开发与制造组织（CDMO）。两家公司今日宣布建立合作关系，联合开展 AATec 旗下主要候选产品 ATL-105 的生产工艺开发与分析方法开发。ATL-105 是一种专有的重组 α1-抗胰蛋白酶（AAT）吸入式疗法，适用于治疗非囊性纤维化支气管扩张症（NCFB）。 more info >> |
|
| Tuesday, July 15, 2025 |
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease |
| AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB). more info >> |
|
| Monday, May 5, 2025 |
|
|
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards |
| Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech's new Gene Therapy Center with dedicated cGMP facilities for virus-related projects. more info >> |
|
| Tuesday, March 4, 2025 |
|
|
Micreos Pharmaceuticals 與生物製劑 CDMO Northway Biotech 合作推動其工程化內溶素療法製造計畫 |
| more info >> |
|
|
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program |
| Micreos Pharmaceuticals AG ("Micreos"), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation, has entered into a strategic partnership with Northway Biotech ("NBT"), a Contract Development and Manufacturing Organization (CDMO) to develop scalable cGMP production processes for Micreos' biologic therapeutic MEndoB, which is the first-in-class dual-active domain targeted medicine that will enter the clinic in the coming months as an investigational therapeutic to treat Atopic Dermatitis. more info >> |
|
| Wednesday, February 5, 2025 |
|
|
Mallia Therapeutics 與 Northway Biotech 宣布合作生產可溶性 CD83 蛋白 用於脫髮治療 |
| Mallia Therapeutics（「Mallia」）是一家致力於開發新型脫髮治療方案的生物製藥公司，Northway Biotech（「NBT」）則是一家專業從事生物製劑的合同開發與製造組織（CDMO）。雙方宣布建立合作夥伴關係，共同開發 Mallia 的可溶性 CD83 蛋白（sCD83）生產工藝，並負責其製造，該治療方案旨在促進毛囊形成與生長。 more info >> |
|
| Tuesday, February 4, 2025 |
|
|
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment |
| Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing novel treatments for hair loss, and Northway Biotech ("NBT"), a biologics Contract Development and Manufacturing Organization (CDMO), have announced a partnership for the development of the production process and manufacturing of Mallia's soluble CD83 protein (sCD83), a treatment aimed at promoting hair follicle formation and growth. more info >> |
|
| Tuesday, August 1, 2023 |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush x Zurich 2026
Apr 7, 2026 11:06 HKT/SGT
|
|
|
Datavault AI 執行長納撒尼爾·T·布拉德利將於 CONV3RGENCE London 及 AssetRush × Zurich 2026 大會發表關於 RWA 代幣化突破性進展的旗艦主題演講
Apr 6, 2026 22:00 HKT/SGT
|
|
|
Datavault AI 首席执行官内森尼尔·T·布拉德利将在 CONV3RGENCE 伦敦峰会及 AssetRush × 苏黎世 2026 峰会上发表关于 RWA 代币化突破性进展的主题演讲
Apr 6, 2026 22:00 HKT/SGT
|
|
|
Honda、「N-BOX」が2025年度 新車販売台数 第1位を獲得
Apr 6, 2026 16:00: JST
|
|
|
JFEと三菱商事、京浜扇島地区における電力事業とデータセンター事業を一体とした共同事業について基本合意書締結
Apr 6, 2026 15:30: JST
|
|
|
JFE Holdings and Mitsubishi Corporation Sign Second MOU to Advance Integrated Power and Data Center Project in Ohgishima, Keihin District
Apr 6, 2026 14:27 JST
|
|
|
The Full Spectrum of K-Culture in One Place: "2026 MyK FESTA" to Open June 25
Apr 3, 2026 23:00: JST
|
|
|
The Full Spectrum of K-Culture in One Place: "2026 MyK FESTA" to Open June 25
Apr 3, 2026 23:00 HKT/SGT
|
|
|
海通恒信2025年報：協同效應加速釋放 新興賽道引領結構升級
Apr 3, 2026 20:28 HKT/SGT
|
|
|
海通恒信2025年报：协同效应加速释放 新兴赛道引领结构升级
Apr 3, 2026 19:43 HKT/SGT
|
|
|
新希望乳業攜手香港十字牌 借道本土老字號共拓港澳市場
Apr 3, 2026 16:51 HKT/SGT
|
|
|
新希望乳业携手香港十字牌 借道本土老字号共拓港澳市场
Apr 3, 2026 16:44 HKT/SGT
|
|
|
新希望乳業與香港十字牌達成戰略合作：雙方充分發揮資源稟賦 助力港澳乳品行業高質量發展
Apr 3, 2026 16:38 HKT/SGT
|
|
|
新希望乳业与香港十字牌达成战略合作：双方充分发挥资源禀赋 助力港澳乳品行业高质量发展
Apr 3, 2026 16:26 HKT/SGT
|
|
|
HKTDC's response to World Trade Organization's latest report
Apr 3, 2026 16:11 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
